Sponsor or institution
Clinical trials and research at MacroGenics
As of November 12, 2026, Find a Trial lists 4 clinical trials run by MacroGenics that are recruiting, at sites in 5 countries (most in United States (4), Australia (1), United Kingdom (1)). By phase: Phase 1 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MGC030 in adults with advanced solid tumors | Phase 1 | Lake Success, New York | Recruiting | Sep 16, 2026 |
| Lorigerlimab for advanced platinum‑resistant and clear‑cell gynecologic cancers | Phase 2 | Los Angeles, California and 15 other locations | Recruiting | Dec 12, 2024 |
| Testing MGC028 in patients with advanced solid tumors | Phase 1 | San Francisco, California and 6 other locations | Recruiting | Dec 9, 2024 |
| Testing MGC026 in patients with advanced solid tumors | Phase 1 | Los Angeles, California and 11 other locations | Recruiting | Feb 5, 2024 |
All recruiting trials (4)
-
MGC030 in adults with advanced solid tumors
This trial tests MGC030 in adults with advanced urothelial, gastric/GEJ, esophageal, colorectal, gastric, pancreatic, or GEJ cancers to see if it is safe and whether it can shrink tumors or stop growth.
-
Lorigerlimab for advanced platinum‑resistant and clear‑cell gynecologic cancers
This trial will test lorigerlimab given by IV every three weeks in people with platinum‑resistant ovarian, fallopian tube, primary peritoneal, or clear‑cell gynecologic cancers.
-
Testing MGC028 in patients with advanced solid tumors
This study is testing a new treatment called MGC028 to see if it is safe and can help adults with advanced solid tumors that can't be removed or have spread.
-
Testing MGC026 in patients with advanced solid tumors
This study is testing a new treatment called MGC026 to see if it can help adults with advanced solid tumors that can't be removed or have spread to other parts of the body.
Quick answers
How many clinical trials run by MacroGenics are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Australia (1 trial), United Kingdom (1 trial), Canada (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.